Loading organizations...
Loading organizations...
Precision oncology targeting virus-associated malignancies.
Viracta Therapeutics has raised $143.4M across 4 funding rounds.
Viracta Therapeutics has raised $143.4M in total across 4 funding rounds.
Viracta Therapeutics has raised $143.4M in total across 4 funding rounds.
Viracta Therapeutics's investors include Oxford Finance, Silicon Valley Bank, Kevin Ye, Forward Ventures, Latterell Venture Partners, NantKwest, VI Ventures, Patrick Soon-Shiong, Wicklow Capital.
Viracta Therapeutics has raised $143.4M across 4 funding rounds. Most recently, it raised $50.0M Debt in November 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 5, 2021 | $50.0M Debt | Oxford Finance, Silicon Valley Bank | |
| Feb 24, 2021 | $65.0M Other Equity | ||
| Dec 4, 2018 | $10.0M Other Equity | Kevin Ye | Forward Ventures, Latterell Venture Partners, NantKwest, VI Ventures |
| Apr 6, 2017 | $18.4M Series B | Patrick Soon-Shiong | Forward Ventures, Latterell Venture Partners, Wicklow Capital |